Navigation Links
Electrospinning: Emerging New Technology at Zeus
Date:2/16/2009

Zeus is developing new technology in the field of electrospinning for applications primarily within the medical device and filtration industries

ORANGEBURG, S.C., Feb. 16 /PRNewswire/ -- Zeus, Inc. announces a new technology platform in the field of electrospinning, a process that produces polymer fibers with thicknesses ranging from the nano to microscale. Zeus is able to develop fabrics with complex shapes from solutions, pastes, and bioabsorbables. The result is a broad range of fiber and fabric properties that are able to meet some of the most challenging demands.

Electrospun polymers produce fibers and fabrics with high surface to weight and volume ratios, which makes these materials excellent candidates for controlled biological interactions and filtration media (stand alone and coding).

In the biological area, the porous nature of the fabric allows for the formation of implantable structures within the body. Cellular growth is allowed as the electrospun fabric acts as a scaffolding to permit integration into the body. In the case of bioabsorbable materials, the scaffolding is eventually absorbed, leaving a structure of the body's own cells intact. To meet application demands, Zeus is able to introduce additives, ranging from therapeutic agents to property modifiers, into the solutions that are then incorporated into the fibers and fabrics.

"Embarking on this new technology platform demonstrates Zeus' long-standing commitment to innovation, research, and superior customer support," said Bruce Anneaux, Corporate Manager, Research and Development. "We are excited about the electrospinning process and what this means for our partners in terms of enhancing and creating new solutions for challenging applications."

About Zeus, Inc.:

Zeus, Inc. is headquartered in Orangeburg, SC, USA. Zeus is a world leader in the design and production of high-performance polymer tubing used in demanding applications, operating multiple facilities in North America and internationally. Zeus products and services are preferred by companies in medical, automotive, electrical, fluid handling, and mechanical markets. For more information, visit http://www.zeusinc.com.

    Press Contact:

    Samantha D. Farlow
    (803) 268-9500

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Zeus, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego
2. Favrille to Present at AG Edwards Emerging Growth Conference and Wall Street Analyst Forum
3. Bionovo to Present at A.G. Edwards 2nd Annual Emerging Growth Conference 2007
4. Kensey Nash to Present at the Sidoti Sixth Annual West Coast Emerging Growth Institutional Investor Forum Conference
5. Medarex to Present at the A.G. Edwards 2nd Annual Emerging Growth Conference
6. Neurocrine Biosciences to Present at the A.G. Edwards Annual Emerging Growth Conference
7. Luminex Corporation to Present at Americas Growth Capital Emerging Growth Conference
8. Project on Emerging Nanotechnologies and Consumers Union collaborate on ConsumersTalkNano
9. NanoMaterials Technology to Conduct Process Development Feasibility Study with US Based Emerging Pharmaceutical Company
10. Clarient CEO Ron Andrews to Participate in OneMedPlace Emerging Healthcare Technologies Finance Forum
11. Kensey Nash to Participate in the Sidoti Fifth Annual Palm Beach Emerging Growth Institutional Investor Forum Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased emissions are ... 5.5 million people each year. Especially those living in larger cities are affected by ... in one of the most pollution-affected countries globally - decided to take action. , ...
(Date:10/10/2017)... (PRWEB) , ... October 10, ... ... development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed ... targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with ...
(Date:10/10/2017)... Calif. , Oct. 10, 2017 SomaGenics ... from the NIH to develop RealSeq®-SC (Single Cell), expected ... for profiling small RNAs (including microRNAs) from single cells ... Program highlights the need to accelerate development of approaches ... "New techniques for measuring levels ...
(Date:10/9/2017)... ... ... The award-winning American Farmer television series will feature 3 Bar Biologics in an ... on RFD-TV. , With global population estimates nearing ten billion people by 2050, ... a growing nation. At the same time, many of our valuable resources are becoming ...
Breaking Biology Technology:
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/29/2017)... , March 29, 2017  higi, the health ... in North America , today announced ... and the acquisition of EveryMove. The new investment and ... set of tools to transform population health activities through ... lifestyle data. higi collects and secures data ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... Forecast to 2025" report to their offering. ... The Global Biometric Vehicle Access System ... over the next decade to reach approximately $1,580 million by 2025. ... forecasts for all the given segments on global as well as ...
Breaking Biology News(10 mins):